2026-01-02 - Analysis Report
Okay, let's break down this UNH stock analysis.

**0. Report in English**

Here's the data organized and analyzed step-by-step:

**1. Return Rate Comparison**

*   **Ticker:** UNH (UnitedHealth Group Inc) - A diversified health care company.
*   **UNH Cumulative Return:** -21.89%
*   **S&P 500 (VOO) Cumulative Return:** 105.07%
*   **Divergence:** -127.0 (Range: -137.7 to 22.4, Relative Divergence: 6.7)

**Analysis:**

UNH significantly underperformed the S&P 500 over the period examined. The divergence is substantial, indicating a large difference in returns.  The relative divergence of 6.7 suggests that this level of underperformance is near the worst observed historically within the given range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta  | Cap(B) |
|------------|--------|-------|---------|-------|--------|
| 2016-2018  | 116.0% | 72.2% | 87.0%   | 0.9   | 225.7  |
| 2017-2019  | 81.0%  | 73.3% | 40.0%   | 0.9   | 266.3  |
| 2018-2020  | 48.0%  | 82.8% | 15.0%   | 1.1   | 317.7  |
| 2019-2021  | 86.0%  | 82.8% | 10.0%   | 1.1   | 454.9  |
| 2020-2022  | 95.0%  | 81.4% | 76.0%   | 0.9   | 480.3  |
| 2021-2023  | 58.0%  | 80.4% | 29.0%   | 0.5   | 476.9  |
| 2022-2024  | 7.0%   | 80.4% | -23.0%  | 0.4   | 458.2  |
| 2023-2025  | -34.0% | 87.8% | -102.0% | 0.3   | 299.0  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Shows a declining trend in recent periods, with the most recent period (2023-2025) being negative.
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant risk.  Drawdown reflects the maximum peak to trough decline in the investment during a specified period.
*   **Alpha:**  Has deteriorated significantly, becoming negative in the last two periods.  Alpha represents the excess return of an investment relative to a benchmark index. Negative Alpha means the investment is underperforming the benchmark.
*   **Beta:** Has generally been declining over time, suggesting UNH is becoming less volatile than the market (S&P 500). Beta is a measure of a stock's volatility in relation to the market. A Beta of less than 1 suggests the stock is less volatile than the market.
*   **Cap(B):** Market Cap in Billions.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 330.11
*   **Previous Close:** 332.16
*   **Change:** -0.62
*   **5-day SMA:** 330.124
*   **20-day SMA:** 331.067
*   **60-day SMA:** 337.7943

**Analysis:**

The stock price is currently slightly down. The 5-day SMA is below the 20-day SMA, which is below the 60-day SMA. This *could* indicate a short-term downward trend, but the differences are small.  The modest difference between the current price and the SMAs suggests the price is in a consolidation phase, but the SMAs are falling.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 51.90
*   **PPO:** 0.0659
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Dividend_2.21 (Cash Ratio: 0% on 2025-12-08)
*   **Recent (20 days) relative divergence change:** 1.9 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** 0.0, Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

**Analysis:**

*   **MRI:** Suggests a medium level of investment risk.
*   **RSI:** At 51.90, the stock is neither overbought nor oversold.
*   **PPO:** Indicates that the price is slightly above its moving averages.
*   **Hybrid Signal:**  Indicates a strong buy signal, suggesting that technical indicators favor an upward movement, especially when dividend yield is accounted for.
*   **Divergence Change:** The positive divergence change suggests recent short-term upward momentum.
*   **Expected Return:** The zero expected return relative to the S&P 500 is concerning and indicates no predicted outperformance in the long term.

**4. Recent News & Significant Events**

*   **UnitedHealthcare delays remote monitoring policy:** Potentially negative for short-term revenue.
*   **UNH vs. ELV Comparison:** Implies uncertainty regarding UNH's relative valuation compared to its peers.
*   **Valuation Reset, Bull Case Still Standing Tall:**  Suggests the market may have re-evaluated UNH, but some analysts still see upside.
*   **3 Risks That Can Make UnitedHealth Stock Unattractive:**  Highlights potential downsides.
*   **Traders Look Ahead to January Guidance:**  Future guidance is important and the market is anticipating it.
*   **Billionaire David Tepper Sells UNH:**  A negative signal, though one sale doesn't always mean a larger trend.

**Analysis:**

The news is mixed. There are concerns about policy changes, risks to the business, and at least one prominent investor selling shares. However, some analysts remain bullish, and the market is anticipating future guidance.
**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.96 on a 1-5 scale)
*   **Target Price:** Average: 392.24, High: 440.00, Low: 280.00
*   **Recent Rating Changes:** No recent changes are listed

**Analysis:**

Despite recent underperformance, analysts generally have a "Buy" rating on UNH. The average target price suggests a significant upside potential from the current price. However, the wide range between the high and low target prices indicates uncertainty among analysts.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-10-28 | 2.59 | 113.16 B$   |
| 2025-08-11 | 3.76 | 111.62 B$   |
| 2025-05-07 | 6.9  | 109.58 B$   |
| 2024-11-04 | 6.56 | 100.82 B$   |
| 2025-10-28 | 6.56 | 100.82 B$   |

**Analysis:**
* Revenue has grown steadily over the past year.
* EPS fluctuates. The earnings seem to have dipped recently compared to the previous quarters, which might concern investors.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-09-30 | $113.16B   | 18.24%        |
| 2025-06-30 | $111.62B   | 17.93%        |
| 2025-03-31 | $109.58B   | 21.70%        |
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE    |
|------------|-------------|--------|
| 2025-09-30 | $95.79B   | 2.45%  |
| 2025-06-30 | $94.72B   | 3.60%  |
| 2025-03-31 | $95.04B   | 6.62%  |
| 2024-12-31 | $92.66B   | 5.98%  |
| 2024-09-30 | $94.53B   | 6.41%  |

**Analysis:**

*   **Revenue:** Shows a consistent increase over the past year.
*   **Profit Margin:** Has declined in recent quarters, which could be a concern.
*   **Equity:** Gradually increasing.
*   **ROE (Return on Equity):** Has significantly decreased recently. This is concerning as it indicates the company is generating less profit from shareholders' equity.

**7. Comprehensive Analysis (Summary)**

**Summary of the Situation**

UNH has significantly underperformed the S&P 500, and recent performance trends are concerning. While analysts generally rate the stock a "Buy" with a potentially significant upside, there are several factors to consider:

*   **Negative Trends:** Declining CAGR, negative alpha, declining profit margins, and falling ROE.
*   **Mixed Signals:** Positive analyst ratings contrast with the news headlines that highlight risks.
*   **Short-Term Positives:** Recent positive short-term momentum is contradicted by the negative overall divergence and concerning recent earnings.
*   **Uncertainty:** Analyst target prices have a wide range, highlighting uncertainty.

**Overall Assessment:**

Based on this analysis, UNH appears to be a risky investment at this time. While analysts remain positive, the negative performance trends, declining profitability, and risks highlighted in the news warrant caution.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.